New Cloud-Based system could transform diabetes care in hospitals
NCT ID NCT05307237
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a continuous glucose monitor (CGM) that sends real-time blood sugar data to a cloud-based dashboard, allowing a remote team to manage high-risk type 2 diabetes patients in the hospital. Over 500 participants were assigned to either the active CGM system or usual care with blinded monitoring. The goal was to improve time in safe blood sugar range and reduce hospital infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dexcom G6 Continuous Glucose Monitor (device)
What this could lead to
If successful, this could lead to better blood sugar management and fewer infections for hospitalized diabetes patients, especially those with limited access to care.
What could go wrong
This is a completed study, but results may not apply to all hospitals or patient groups. The device requires proper training and may have technical issues or skin reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Scripps Mercy Hospital
Chula Vista, California, 91910, United States